These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8288624)

  • 1. Functional domains of aromatase cytochrome P450 inferred from comparative analyses of amino acid sequences and substantiated by site-directed mutagenesis experiments.
    Chen S; Zhou D
    J Biol Chem; 1994 Jan; 269(2):1564. PubMed ID: 8288624
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional domains of aromatase cytochrome P450 inferred from comparative analyses of amino acid sequences and substantiated by site-directed mutagenesis experiments.
    Chen S; Zhou D
    J Biol Chem; 1992 Nov; 267(31):22587-94. PubMed ID: 1429608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional domains of human aromatase cytochrome P450 characterized by linear alignment and site-directed mutagenesis.
    Amarneh B; Corbin CJ; Peterson JA; Simpson ER; Graham-Lorence S
    Mol Endocrinol; 1993 Dec; 7(12):1617-24. PubMed ID: 8145767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A detailed molecular model for human aromatase.
    Laughton CA; Zvelebil MJ; Neidle S
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):399-407. PubMed ID: 8476753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function studies of human aromatase.
    Chen S; Zhou D; Swiderek KM; Kadohama N; Osawa Y; Hall PF
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):347-56. PubMed ID: 8476748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing events in the coding region of the cytochrome P450 aromatase gene in male rat germ cells.
    Levallet J; Mittre H; Delarue B; Carreau S
    J Mol Endocrinol; 1998 Jun; 20(3):305-12. PubMed ID: 9687153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinants of aromatase cytochrome p450 inhibition in substrate recognition site-1.
    Conley A; Mapes S; Corbin CJ; Greger D; Graham S
    Mol Endocrinol; 2002 Jul; 16(7):1456-68. PubMed ID: 12089342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking CoMFA and protein homology models of enzyme-inhibitor interactions: an application to non-steroidal aromatase inhibitors.
    Cavalli A; Greco G; Novellino E; Recanatini M
    Bioorg Med Chem; 2000 Dec; 8(12):2771-80. PubMed ID: 11131168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular model for the interaction between vorozole and other non-steroidal inhibitors and human cytochrome P450 19 (P450 aromatase).
    Koymans LM; Moereels H; Vanden Bossche H
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):191-7. PubMed ID: 7626453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-dimensional model of aromatase cytochrome P450.
    Graham-Lorence S; Amarneh B; White RE; Peterson JA; Simpson ER
    Protein Sci; 1995 Jun; 4(6):1065-80. PubMed ID: 7549871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking for selectivity among cytochrome P450s inhibitors.
    Cavalli A; Recanatini M
    J Med Chem; 2002 Jan; 45(2):251-4. PubMed ID: 11784128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional model of cytochrome P450 human aromatase.
    Loge C; Le Borgne M; Marchand P; Robert JM; Le Baut G; Palzer M; Hartmann RW
    J Enzyme Inhib Med Chem; 2005 Dec; 20(6):581-5. PubMed ID: 16408794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modelling of steroidogenic cytochromes P450 from families CYP11, CYP17, CYP19 and CYP21 based on the CYP102 crystal structure.
    Lewis DF; Lee-Robichaud P
    J Steroid Biochem Mol Biol; 1998 Aug; 66(4):217-33. PubMed ID: 9744519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenesis study at a postulated hydrophobic region near the active site of aromatase cytochrome P450.
    Zhou D; Cam LL; Laughton CA; Korzekwa KR; Chen S
    J Biol Chem; 1994 Jul; 269(30):19501-8. PubMed ID: 8034720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence analysis and expression of the P450 aromatase and estrogen receptor genes in the Xenopus ovary.
    Miyashita K; Shimizu N; Osanai S; Miyata S
    J Steroid Biochem Mol Biol; 2000 Dec; 75(2-3):101-7. PubMed ID: 11226826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding characteristics of seven inhibitors of human aromatase: a site-directed mutagenesis study.
    Kao YC; Cam LL; Laughton CA; Zhou D; Chen S
    Cancer Res; 1996 Aug; 56(15):3451-60. PubMed ID: 8758911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site-directed mutagenesis.
    Graham-Lorence S; Khalil MW; Lorence MC; Mendelson CR; Simpson ER
    J Biol Chem; 1991 Jun; 266(18):11939-46. PubMed ID: 2050688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three-dimensional model of CYP19 aromatase for structure-based drug design.
    Karkola S; Höltje HD; Wähälä K
    J Steroid Biochem Mol Biol; 2007; 105(1-5):63-70. PubMed ID: 17583493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of a goldfish brain cytochrome P450 aromatase cDNA: mRNA expression during the seasonal cycle and after steroid treatment.
    Gelinas D; Pitoc GA; Callard GV
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):81-93. PubMed ID: 9685217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of multiple CYP19 genes encoding different cytochrome P450 aromatase isozymes in brain and ovary.
    Tchoudakova A; Callard GV
    Endocrinology; 1998 Apr; 139(4):2179-89. PubMed ID: 9529008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.